---
title: "Foundayo (orforglipron) in chronic weight management: Dosing and administration questions"
description: "Dosing and administration questions on Foundayo (orforglipron) in chronic weight management, each answered with verbatim quotes from the manufacturer's US website for healthcare professionals or documents it links. Topics: Administration and Dosing. Questions: Is Foundayo a pill or an injection? What is the Foundayo dosing schedule? What is the maximum dose of Foundayo? How should Foundayo be taken? 5 further questions follow. 9 questions quoted from 2 sources."
canonical: "https://www.evicenter.com/medical-information/foundayo--chronic-weight-management/dosing-and-administration"
published: "2026-11-14T00:11:41-05:00"
modified: "2026-11-14T16:49:54-05:00"
---

# Foundayo (orforglipron) in chronic weight management: Dosing and administration questions

Manufacturer: Lilly USA, LLC  
Prescribing information: [Foundayo](https://uspl.lilly.com/foundayo/foundayo.html#pi)

## Administration

<a id="foundayo-pill-or-injection"></a>

### Is Foundayo a pill or an injection?

> “FOUNDAYO (orforglipron) tablets, for oral use”

Source: [FOUNDAYO: Prescribing information, captured 2026-11-14](https://uspl.lilly.com/foundayo/foundayo.html#pi:~:text=FOUNDAYO%20%28orforglipron%29%20tablets%2C%20for%20oral%20use)

> “Take FOUNDAYO orally once daily, with or without food.”

Source: [FOUNDAYO: Prescribing information, captured 2026-11-14](https://uspl.lilly.com/foundayo/foundayo.html#pi:~:text=Recommended%20Administration-,Take%20FOUNDAYO%20orally%20once%20daily%2C%20with%20or%20without%20food.)

> “FOUNDAYO is only for oral use.”

Source: [FOUNDAYO: Prescribing information, captured 2026-11-14](https://uspl.lilly.com/foundayo/foundayo.html#pi:~:text=FOUNDAYO%20is%20only%20for%20oral%20use.)

<a id="foundayo-how-to-take"></a>

### How should Foundayo be taken?

> “Take FOUNDAYO orally once daily, with or without food.
> Swallow tablets whole. Do not break, crush, or chew.
> Do not take more than one tablet per day.”

Source: [FOUNDAYO: Prescribing information, captured 2026-11-14](https://uspl.lilly.com/foundayo/foundayo.html#pi:~:text=Recommended%20Administration-,Take%20FOUNDAYO%20orally%20once%20daily%2C%20with%20or%20without%20food.,than%20one%20tablet%20per%20day.)

<a id="foundayo-crush-or-split"></a>

### Can Foundayo tablets be crushed, split, or chewed?

> “Swallow tablets whole. Do not break, crush, or chew.”

Source: [FOUNDAYO: Prescribing information, captured 2026-11-14](https://uspl.lilly.com/foundayo/foundayo.html#pi:~:text=or%20without%20food.-,Swallow%20tablets%20whole.%20Do%20not%20break%2C%20crush%2C%20or%20chew.)

> “Advise patients to swallow tablets whole and not to break, crush, or chew tablets [see Dosage and Administration (2.1)].”

Source: [FOUNDAYO: Prescribing information, captured 2026-11-14](https://uspl.lilly.com/foundayo/foundayo.html#pi:~:text=Advise%20patients%20to%20swallow%20tablets,%5Bsee%20Dosage%20and%20Administration%20%282.1%29%5D.)

<a id="foundayo-food"></a>

### Can Foundayo be taken with food?

> “Take FOUNDAYO orally once daily, with or without food.”

Source: [FOUNDAYO: Prescribing information, captured 2026-11-14](https://uspl.lilly.com/foundayo/foundayo.html#pi:~:text=Recommended%20Administration-,Take%20FOUNDAYO%20orally%20once%20daily%2C%20with%20or%20without%20food.)

> “No clinically relevant food effect on orforglipron exposure was observed. Following multiple doses of an investigational 37.5 mg orforglipron tablet, the AUC(0-24h) decreased by 19%, and Cmax decreased by 26% with food compared to fasted state. The tmax and t1/2 were unchanged.”

Source: [FOUNDAYO: Prescribing information, captured 2026-11-14](https://uspl.lilly.com/foundayo/foundayo.html#pi:~:text=No%20clinically%20relevant%20food%20effect,tmax%20and%20t1%2F2%20were%20unchanged.)

## Dosing

<a id="foundayo-dosing-schedule"></a>

### What is the Foundayo dosing schedule?

> “Follow the FOUNDAYO starting dosage and escalation described below to reduce the risk of gastrointestinal (GI) adverse reactions [see Warnings and Precautions (5.3), Adverse Reactions (6)].
>
> The starting dosage is 0.8 mg orally once daily. After at least 30 days on the 0.8 mg dosage, increase the dosage to 2.5 mg once daily.
> After at least 30 days on the 2.5 mg dosage, increase the dosage to 5.5 mg once daily.
> The dosage may be increased to the next dosage level (9 mg, 14.5 mg, or 17.2 mg once daily) after at least 30 days on the current dosage, based on treatment response and tolerability.
> The maximum dosage of FOUNDAYO is 17.2 mg once daily.”

Source: [FOUNDAYO: Prescribing information, captured 2026-11-14](https://uspl.lilly.com/foundayo/foundayo.html#pi:~:text=Follow%20the%20FOUNDAYO%20starting%20dosage,is%2017.2%20mg%20once%20daily.)

> “Consider treatment response and tolerability when selecting treatment dosage.”

Source: [FOUNDAYO: Foundayo™ (orforglipron) Dosing Schedule & Safety Information, captured 2026-11-14](https://foundayo.lilly.com/hcp/dosage#:~:text=Consider%20treatment%20response%20and%20tolerability%20when%20selecting%20treatment%20dosage.)

<a id="foundayo-max-dose"></a>

### What is the maximum dose of Foundayo?

> “The maximum dosage of FOUNDAYO is 17.2 mg once daily.”

Source: [FOUNDAYO: Prescribing information, captured 2026-11-14](https://uspl.lilly.com/foundayo/foundayo.html#pi:~:text=The%20maximum%20dosage%20of%20FOUNDAYO%20is%2017.2%20mg%20once%20daily.)

> “The maximum dosage of FOUNDAYO is 9 mg once daily when used concomitantly with a strong CYP3A4 inhibitor [see Drug Interactions (7.1), Clinical Pharmacology (12.3)].”

Source: [FOUNDAYO: Prescribing information, captured 2026-11-14](https://uspl.lilly.com/foundayo/foundayo.html#pi:~:text=when%20taking%20FOUNDAYO.-,The%20maximum%20dosage%20of%20FOUNDAYO%20is%209%20mg%20once%20daily,Interactions%20%287.1%29%2C%20Clinical%20Pharmacology%20%2812.3%29%5D.)

> “Do not take more than one tablet per day.”

Source: [FOUNDAYO: Prescribing information, captured 2026-11-14](https://uspl.lilly.com/foundayo/foundayo.html#pi:~:text=crush%2C%20or%20chew.-,Do%20not%20take%20more%20than%20one%20tablet%20per%20day.)

<a id="foundayo-missed-dose"></a>

### What should patients do after a missed Foundayo dose?

> “If a dose is missed, instruct patients to take the dose as soon as possible.
> Advise patients not to double up the next dose.
> If 7 or more consecutive doses are missed, reinitiate dosage escalation at a lower dosage to reduce the risk of gastrointestinal adverse reactions [see Dosage and Administration (2.1), Warnings and Precautions (5.3), Adverse Reactions (6)].”

Source: [FOUNDAYO: Prescribing information, captured 2026-11-14](https://uspl.lilly.com/foundayo/foundayo.html#pi:~:text=If%20a%20dose%20is%20missed%2C,Precautions%20%285.3%29%2C%20Adverse%20Reactions%20%286%29%5D.)

<a id="foundayo-reduce-gi-side-effects"></a>

### How can Foundayo nausea and stomach side effects be reduced?

> “Follow the FOUNDAYO starting dosage and escalation described below to reduce the risk of gastrointestinal (GI) adverse reactions [see Warnings and Precautions (5.3), Adverse Reactions (6)].”

Source: [FOUNDAYO: Prescribing information, captured 2026-11-14](https://uspl.lilly.com/foundayo/foundayo.html#pi:~:text=Follow%20the%20FOUNDAYO%20starting%20dosage,Precautions%20%285.3%29%2C%20Adverse%20Reactions%20%286%29%5D.)

> “If 7 or more consecutive doses are missed, reinitiate dosage escalation at a lower dosage to reduce the risk of gastrointestinal adverse reactions [see Dosage and Administration (2.1), Warnings and Precautions (5.3), Adverse Reactions (6)].”

Source: [FOUNDAYO: Prescribing information, captured 2026-11-14](https://uspl.lilly.com/foundayo/foundayo.html#pi:~:text=If%207%20or%20more%20consecutive,Precautions%20%285.3%29%2C%20Adverse%20Reactions%20%286%29%5D.)

> “Inform patients of the potential risk of severe gastrointestinal adverse reactions. Instruct patients to contact their healthcare provider if they have severe or persistent gastrointestinal symptoms [see Warnings and Precautions (5.3)].”

Source: [FOUNDAYO: Prescribing information, captured 2026-11-14](https://uspl.lilly.com/foundayo/foundayo.html#pi:~:text=Inform%20patients%20of%20the%20potential%20risk%20of,%5Bsee%20Warnings%20and%20Precautions%20%285.3%29%5D.)

<a id="foundayo-cyp3a4-dose-adjustment"></a>

### Does Foundayo need a dose change with CYP3A4 inhibitors or inducers?

> “FOUNDAYO dosage modification may be required to manage interactions with some concomitant medications [see Drug Interactions (7.1), Clinical Pharmacology (12.3)].
>
> Strong CYP3A4 Inhibitors
>
> Avoid strong CYP3A4 inhibitors that also inhibit OATP1B when taking FOUNDAYO.
> The maximum dosage of FOUNDAYO is 9 mg once daily when used concomitantly with a strong CYP3A4 inhibitor [see Drug Interactions (7.1), Clinical Pharmacology (12.3)].
>
> Strong and Moderate CYP3A4 Inducers
>
> Avoid strong CYP3A4 inducers when taking FOUNDAYO.
> Monitor FOUNDAYO effectiveness when concomitantly using moderate CYP3A4 inducers and escalate FOUNDAYO dosage as needed [see Dosage and Administration (2.1, 2.3), Drug Interactions (7.1), Clinical Pharmacology (12.3)].”

Source: [FOUNDAYO: Prescribing information, captured 2026-11-14](https://uspl.lilly.com/foundayo/foundayo.html#pi:~:text=FOUNDAYO%20dosage%20modification%20may%20be,2.3%29%2C%20Drug%20Interactions%20%287.1%29%2C%20Clinical%20Pharmacology%20%2812.3%29%5D.)

## Related pages
- [Medical information: Foundayo (orforglipron): Chronic weight management](https://www.evicenter.com/medical-information/foundayo--chronic-weight-management)
- [Indication](https://www.evicenter.com/medical-information/foundayo--chronic-weight-management/indication)
- [Pharmacology](https://www.evicenter.com/medical-information/foundayo--chronic-weight-management/pharmacology)
- [Clinical trials](https://www.evicenter.com/medical-information/foundayo--chronic-weight-management/clinical-trials)
- [Safety](https://www.evicenter.com/medical-information/foundayo--chronic-weight-management/safety)
- [Specific populations](https://www.evicenter.com/medical-information/foundayo--chronic-weight-management/specific-populations)
- [Drug interactions](https://www.evicenter.com/medical-information/foundayo--chronic-weight-management/drug-interactions)
- [Storage and supply](https://www.evicenter.com/medical-information/foundayo--chronic-weight-management/storage-and-supply)
- [Access and coverage](https://www.evicenter.com/medical-information/foundayo--chronic-weight-management/access-and-coverage)
